Gabriel Cian on building the 2060 longevity ecosystem
Gabriel Cian is building the 2060 longevity ecosystem as an interconnected network—not just a conference. In a July 13 follow-up interview with Lifespan.io, the 2060 Foundation founder explains how preventive medicine, investor education, and new vehicles like the 3060 Fund of Funds are meant to channel capital toward defeating aging before 2060.
One year after the first 2060 Longevity Forum, Cian says his biggest lesson is that the fastest route to radical life extension is often not a straight line. Governments, scientists, and the public still resist futuristic biotech, but preventive medicine is accelerating with far less friction.
Key Takeaways
- Cian argues longevity progress should ride the preventive-medicine wave first, then redirect a slice of that capital into aging R&D.
- The 2025 Forum helped startups raise funding and inspired the 3060 Fund of Funds, a diversified longevity investment vehicle.
- The 2026 Forum shifts toward educating more investors while the 2060 Club, Ikare.Health, and 3060.vc reinforce the wider ecosystem.
- Cian's 2026 goal is establishing the 2060 Foundation as Europe's leading longevity promotion organization.
Why isn't the shortest path to defeat aging a straight line?
Cian compares the mission to a river: mathematically, the shortest path is direct, but society meets massive resistance to radical life extension. Preventive medicine—lifestyle changes, diagnostics, supplementation—faces far less pushback and attracts heavy investment.
His bet is that even 1% of preventive medicine's capital could exceed what flows directly into biotech today. That philosophy now shapes both policy patience and portfolio strategy across the 2060 ecosystem.
What grew out of the first 2060 Longevity Forum?
The 2025 edition in southern France centered on capital. Venture funds sought limited partners, startups pitched investors, and several companies confirmed post-forum funding. Participants also flagged practical fixes—the 2026 event will address menu feedback, including more protein alongside longevity-friendly nutrition.
The bigger structural outcome was the 3060 Fund of Funds. After a real-estate investor pointed out that longevity spans too many sectors for any individual to track, Cian built a vehicle designed to back roughly five top longevity VC funds and expose investors to about 250 startups—what he calls the closest thing to an S&P 500 for longevity.
For the 2026 forum, the team is recruiting more investors and showcasing a broader mix of speakers and startups. Cian deliberately pairs skeptics, clinicians, biotech founders, and futurists so attendees hear conflicting timelines rather than an echo chamber.
How does the 2060 ecosystem fit together in 2026?
Each piece reinforces the others. The longevity and biohacking audience may recognize parallels in adjacent science—such as senolytic-stem-cell combos tested in mice and proposals to study aging in underground labs shielded from muon radiation—but Cian's focus is capital and culture.
The 2060 Club lets smaller investors co-invest $5,000–$20,000 per startup alongside Cian through SPVs targeting about $500,000 per round. Ikare.Health applies an 80/20 rule to preventive care. The annual forum brings founders, physicians, and backers together in person.
Cian still envisions a permanent southern France longevity campus, but today most work is virtual. His 2026 benchmark: make the 2060 Foundation the leading European voice channeling investment toward aging research—34 years before his 2060 deadline.
Read the full interview at Lifespan.io.